Letter by Zito et al Regarding Article, "Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)"

被引：0
|
作者：
Zito, Stefano [1 ]
Lattanzio, Francesco [1 ]
Di Nisio, Marcello [2 ]
机构：
[1] Univ G DAnnunzio Fdn, Internal Med Unit, Ctr Aging Sci, Dept Med & Aging, Chieti, Italy
[2] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy
来源：
STROKE | 2014年 / 45卷 / 09期
关键词：
OLDER-ADULTS;
D O I：
10.1161/STROKEAHA.114.006267
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E191 / E191
页数：1
相关论文
共 50 条
  • [41] Randomized study of aspirin versus warfarin for high-risk mitral rheumatic atrial fibrillation patients
    Lavitola, PL
    Spina, GS
    Tarasoutchi, F
    Sampaio, RO
    Nigri, M
    Grinberg, M
    CIRCULATION, 2002, 106 (19) : 526 - 526
  • [42] Randomized study of aspirin versus warfarin for high-risk mitral rheumatic atrial fibrillation patients
    Lavitola, PL
    Spina, GS
    Sampaio, RO
    Tarasoutchi, F
    Nigri, M
    Grinberg, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 411 - 411
  • [43] Response by Wetmore et al to Letter Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation"
    Wetmore, James B.
    Roetker, Nicholas S.
    Herzog, Charles A.
    STROKE, 2020, 51 (12) : E363 - E364
  • [44] Letter regarding article by Gage et al, "selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin" - Response
    Gage, BF
    van Walraven, C
    Pearce, L
    Hart, RG
    Koudstaal, PJ
    Boode, BSP
    Petersen, P
    CIRCULATION, 2005, 111 (25) : E455 - E456
  • [45] Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis"
    Bai, Ying
    Shantsila, Alena
    Lip, Gregory Y. H.
    STROKE, 2017, 48 (06) : E149 - E149
  • [46] Letter by Romani et al Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation"
    Romani, Federico
    Monasky, Michelle M.
    Pappone, Carlo
    CIRCULATION, 2021, 144 (18) : E280 - E281
  • [47] Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy"
    Rowin, Ethan J.
    Maron, Martin S.
    Maron, Barry J.
    CIRCULATION, 2018, 137 (23) : 2541 - 2542
  • [48] A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation
    Nin, Takamitsu
    Sairaku, Akinori
    Yoshida, Yukihiko
    Kamiya, Hiroki
    Tatematsu, Yasushi
    Nanasato, Mamoru
    Inden, Yasuya
    Hirayama, Haruo
    Murohara, Toyoaki
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (02): : 172 - 179
  • [49] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
    Connolly, S.
    Pogue, J.
    Hart, R.
    Pfeffer, M.
    Hohnloser, S.
    Chrolavicius, S.
    Yusuf, S.
    LANCET, 2006, 367 (9526): : 1903 - 1912
  • [50] Letter by Barrios et al Regarding Article, "Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study" Response
    Go, Alan S.
    Udaltsova, Natalia
    Pomernacki, Niela K.
    Fang, Margaret C.
    Chang, Yuchiao
    Borowsky, Leila
    Singer, Daniel E.
    CIRCULATION, 2009, 120 (18) : E154 - E154
12345